PDCD1 and neoplasm: On the other hand, the percentage of Foxp3 + Treg in CD4 + T cells within the tumour was significantly decreased with the administration of anti-PD-1 antibody (Control; 39.5 ± 6.7%, 4H2; 21.2 ± 3.2%.